Investorview – Zishan Haroon, Chairman & General P...
In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...
Read MoreOur ongoing mission at Biotech and Money is to forge a fundamentally better...
Read MoreBiotech and Money recently caught up with Europe and UK patent attorney Iso...
Read MoreBiotech and Money had the opportunity to speak to Andy Smith CIO of Mann Bi...
Read MoreWe recently spoke to Andy Richards, Serial Biotechnology Entrepreneur and B...
Read MoreWe recently spoke toPeter George, CEO, Clinigen at Biotech and Money London...
Read MoreOn the 2nd and 3rd February, Biotech and Money London welcome over 360 of t...
Read MoreEver since the collapse of British Biotech more than a decade ago, the UK l...
Read MoreThe UK’s leading life science and healthcare company CEO’s, leading investo...
Read MoreAt the 2nd annual Biotech and Money London conference, we’re all about givi...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreBiotech and Money recently caught up with Mark Denham, Fund Manager and Hea...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
In partnership with Medius Associates
Medius' monthly review of the top deals by value in the healthcare sector
Connecting Europe's Life Science corporates with capital.
Biotech and Money is the influential community of senior life science decision makers
© 2016 All Rights Reserved By Biotech and Money
Add Your Response